Xebra Brands Ltd. XBRAF XBRA (FSE:9YC) announced a 5 to 1 share consolidation and a non-brokered private placement of up to 8 million units of Xebra priced, on a post-consolidated basis, at $0.075 per unit for gross proceeds of up to $600,000.
Each unit will be comprised of one common share of the company and one common share purchase warrant. Each warrant will entitle the holder thereof to acquire one common share at an exercise price of CA$0.1 per warrant share at any time for a period of eighteen months following the closing of the financing. It is expected that the closing of the offering will be on or about March 1st, 2023 or such other date or dates that Xebra may determine, subject to the receipt of all required regulatory approval, including acceptance of the Canadian Securities Exchange.
Xebra intends to consolidate its issued and outstanding share capital on the basis of 1 post-consolidation share for each 5 pre-consolidation common shares. Any fraction of a common share will be rounded up or down to the nearest whole number. The common shares will are expected begin trading on a consolidated basis and with a new CUSIP number on February 28, 2023, subject to the regulatory approvals, including the approval of the CSE.
As a result of the consolidation, the outstanding common shares of Xebra will be reduced to approximately 39.34 million, on a pre-offering basis. In the event the offering is fully subscribed, it is expected that Xebra will have a total of 47.34 million common shares issued and outstanding. Xebra will not be changing its name or trading symbol in connection with the consolidation.
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.
Photo by Ryan Lange on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.